Zydus Wellness FY26 profit halves to ₹197 cr even as revenue jumps 46% to ₹3,940 cr

Integration costs from Naturell acquisition weighed on bottomline despite strong topline growth. Sugar Free holds 96.1% category share, Glucon-D 58.9%. RiteBite Max Protein scaling toward double-digit EBITDA margins. EBITDA up 34.2% to ₹509 cr; final dividend ₹1.20/share declared.

— Source publishedMon, 18 May, 2026, 13:47 IST·First seen Mon, 18 May, 2026, 14:02 IST·Source The Hindu BusinessLine

What happened

Zydus Wellness FY26 net profit halved to ₹197 cr despite 46% revenue growth to ₹3,940 cr, weighed by integration costs. Sugar Free, Glucon-D retain category

Key facts

  • FY26 net profit ₹197 cr (-47% YoY)
  • Q4 net profit ₹162 cr (-6% YoY)
  • Q4 revenue ₹1,476 cr (+62.1%)
  • FY26 net sales ₹3,940 cr (+46.4%)
  • EBITDA ₹509 cr (+34.2%)
  • Final dividend ₹1.20/share
  • Sugar Free 96.1% market share
  • Glucon-D 58.9% market share

Why this matters

Zydus is digesting Naturell at a clear earnings cost, signaling the FMCG health-foods M&A playbook still demands 18-24 month patience on integration accretion.

Also reported by